{
  "chapter": "Paediatric Hemato-oncology",
  "questions": [
    {
      "q_no": 1,
      "question": "Question 1: Cancer-'The emperor of all maladies spares no one'. Which of the following is the most \ncommon childhood malignancy?",
      "options": {
        "a": "Neuroblastoma",
        "b": "Astrocytoma",
        "c": "Acute lymphoblastic leukemia",
        "d": "Acute myeloid leukemia"
      },
      "correct_answer": "c",
      "explanation": "Leukemias are the most common childhood malignancies. Among these, acute lymphoblastic \nleukemia (ALL) is the most common, accounting for about 77% of childhood leukemias. Most commons in childhood malignancies: • Second most common malignancy in childhood: Brain tumor • Third most common malignancy in children: Lymphoma • Most common solid tumor in children: Brain tumor",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Paediatric Hemato-oncology"
    },
    {
      "q_no": 2,
      "question": "Question 2: You are asked to review an article titled, 'Childhood cancers- a menace'. Which of the \nfollowing statements is wrong and needs to be edited out?",
      "options": {
        "a": "Acute lymphoblastic leukemia is the most common type of leukemia in children with Down ",
        "b": "The most common intra-abdominal malignancy is Wilm’s tumor.",
        "c": "The most common extracranial solid malignancy is neuroblastoma.",
        "d": "The most common brain tumors in children are infratentorial."
      },
      "correct_answer": "b",
      "explanation": "The most common intraabdominal malignancy in children is neuroblastoma. • The most common leukemias seen in Down’s syndrome: acute lymphoblastic leukemia (ALL) \n&gt; acute myeloid leukemia (AML) • The most common site of a brain tumor in children: Infratentorium • The most common extra-cranial solid neoplasm in children: Neuroblastoma • The most common intra-abdominal neoplasm in children: Neuroblastoma • The most common primary neoplasm of renal tissue in children: Wilm’s tumor 649 \nSold by @itachibot",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Paediatric Hemato-oncology"
    },
    {
      "q_no": 3,
      "question": "Question 3: What is the most common leukemia you would encounter in a child with the following \nfindings? 640 \nSold by @itachibot",
      "options": {
        "a": "Acute myeloid leukemia",
        "b": "Acute lymphoblastic leukemia",
        "c": "Chronic myeloid leukemia",
        "d": "Chronic lymphoid leukemia"
      },
      "correct_answer": "b",
      "explanation": "The image shows a typical Down's facies (flattened nose, flat occiput, low set ears, protruding \ntongue). The most common leukemia in children with Down syndrome is acute lymphoblastic \nleukemia (ALL). Children with Down syndrome are at increased risk of both acute lymphoid leukemia (ALL) and \nacute myeloid leukemia (AML). 10% of neonates with Down's syndrome develop transient leukemia or myeloproliferative \ndisorder. These features usually resolve within the first 3 months of life. However, they require \nclose follow-up, because 20–30% will develop typical leukemia (often acute megakaryocytic \nleukemia) by 3 years of life. Note: • Most common leukemia in Down's syndrome: B-cell Acute lymphoblastic leukemia (overall) • The most common leukemia in children &lt;3years of age with Down syndrome is acute myeloid \nleukemia (AML). • Most common AML in Down's syndrome: M7/megakaryoblastic",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/mxpediatrics/Paediatric_Hemato-oncology_Q3_q.jpg",
      "explanation_image": null,
      "chapter_heading": "Paediatric Hemato-oncology"
    },
    {
      "q_no": 4,
      "question": "Question 4: Jeevit, a 7-year-old boy brought to you by his mother, complains of bone pain so severe that \nhe cannot sleep. Investigations reveal:",
      "options": {
        "a": "TdT+,HLA DR+,CD20+, Cy Ig +",
        "b": "CD19+, CD20+, CD24+, Surface Ig+",
        "c": "CD3+, CD4+, CD5+, CD34+",
        "d": "CD2+, CD7+, TdT+"
      },
      "correct_answer": "a",
      "explanation": "B-lymphoblastic leukemia(pre-B-ALL) is the most common immunophenotype with TdT+,HLA \nDR+, CD10+, CD19+, CD20+, CD24+, Cy Ig + , with onset at 1-10 years of age. The most common type of acute lymphoblastic leukemia (ALL) in children is B-lymphoblastic \nleukemia (previously termed pre-B-ALL) Based on current WHO classification: The most common subtype of ALL is B lymphoblastic \nleukemia &gt; T lymphoblastic leukemia &gt; Mature B-cell Leukemia (Burkitt leukemia) The production of symptoms and signs of ALL is a result of the replacement of bone marrow by \nmalignant cells and caused by secondary bone marrow failure. On physical examination, findings \nof pallor, listlessness, purpuric/petechial skin lesions, or mucous membrane hemorrhage can \nreflect bone marrow failure. The proliferative nature of the disease may be manifested as \nlymphadenopathy, splenomegaly, or, less often, hepatomegaly. At presentation 75% of patients \nhave leukocyte counts of &lt;20,000/µL; thrombocytopenia is seen in 75% of patients and \nhepatosplenomegaly in 30–40% of patients. Patients with joint pain may have evidence of joint \nswelling and effusion. Deep bone pain may be present with marrow involvement, but tenderness \nwill not be elicited.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Paediatric Hemato-oncology"
    },
    {
      "q_no": 5,
      "question": "Question 5: You are posted in the pediatric hematology department as a first-year postgraduate. All of the \nfollowing cases you encounter are at an increased risk of developing leukemias except:",
      "options": {
        "a": "1,4",
        "b": "2,5",
        "c": "1,3,4",
        "d": "5 only"
      },
      "correct_answer": "b",
      "explanation": "650 \nSold by @itachibot Fanconi’s anemia (not syndrome) predisposes to the development of childhood leukemias eg: \nB-ALL due to defective DNA repair. Fanconi syndrome is a syndrome of inadequate reabsorption \nin the proximal renal tubules. Congenital pernicious anemia does not predispose to leukemias. Factors predisposing to childhood leukemias • Genetic conditions: • Fanconi’s anemia • Bloom syndrome • Ataxia telangiectasia • Li-Fraumeni syndrome • Down syndrome • Severe combined immunodeficiency • Neurofibromatosis 1 • Paroxysmal nocturnal hemoglobinuria • Diamond-Blackfan anemia • Schwachman diamond syndrome • Kostmann syndrome • Environmental factors: • Ionizing radiation • Alkylating agents • Nitrosoureas • Epipodophyllotoxin • Benzene exposure • Advanced maternal age.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Paediatric Hemato-oncology"
    },
    {
      "q_no": 6,
      "question": "Question 6: To diagnose a 5-year-old child with acute lymphoblastic leukemia, a pathologist has to see at \nleast  \n percentage of blast cells in a bone marrow biopsy.",
      "options": {
        "a": "15",
        "b": "10",
        "c": "25",
        "d": "30"
      },
      "correct_answer": "c",
      "explanation": "The lower cut-off percentage for diagnosing acute lymphoblastic leukemia on bone marrow biopsy \nis 25%. Unlike with myeloid leukemias, there is no agreed-upon lower limit for the proportion of blasts \nrequired to establish a diagnosis of lymphoblastic leukemia (ALL). In general, the diagnosis \nshould be avoided when there are &lt; 20% blasts. The image below shows numerous lymphoblasts seen on a peripheral smear. 651 \nSold by @itachibot Work-up of ALL: It is important that all studies necessary to confirm a diagnosis and adequately classify the type of \nleukemia be performed, including bone marrow aspiration and biopsy, flow cytometry, \ncytogenetics, and molecular studies. The initial evaluation should also include a CSF examination. \nIf lymphoblasts are found and the CSF leukocyte count is elevated, overt CNS or meningeal \nleukemia is present. This finding reflects a poorer stage and indicates the need for additional CNS \nand systemic therapies.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Paediatric Hemato-oncology"
    },
    {
      "q_no": 7,
      "question": "Question 7: A 4-year-old child who was being evaluated for pancytopenia is diagnosed with acute \nlymphoblastic leukemia. Which of the following findings would indicate a poor prognosis?",
      "options": {
        "a": "Minimal residual disease&gt;0.01% at the end of induction therapy",
        "b": "t(12,21) on cytogenetic study",
        "c": "Early B- cell immunophenotype.",
        "d": "Initial WBC count of 20,000 cells/mm3"
      },
      "correct_answer": "a",
      "explanation": "MRD(Minimal residual disease) is a quantitative estimate of the burden of leukemic cells present \nin marrow. MRD&gt;0.01%at the end of induction suggests a poorer prognosis. Initial WBC count of &lt;50,000cells/mm3, B-cell immunophenotype and t(12,21) indicate a \nstandard risk(Favourable prognosis) Risk-directed therapy is the standard of current ALL treatment and accounts for: • Age at diagnosis • Initial WBC count • Immunophenotypic and cytogenetic characteristics of blast populations • The rapidity of early treatment response (i.e., how quickly the leukemic cells can be cleared from \nthe marrow or peripheral blood) • Assessment of MRD at the end of induction therapy.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Paediatric Hemato-oncology"
    },
    {
      "q_no": 8,
      "question": "Question 8: A 14-year-old boy is rushed to the casualty due to difficulty in breathing and swelling of the \nface and neck. Clinically, he has features suggestive of superior vena cava obstruction. Chest \nX-ray image shows superior mediastinal widening. Which of the following is the most likely \ndiagnosis?",
      "options": {
        "a": "B-cell acute lymphoblastic leukemia",
        "b": "T-cell acute lymphoblastic leukemia",
        "c": "Chronic myeloid leukemia",
        "d": "Chronic lymphocytic leukemia"
      },
      "correct_answer": "b",
      "explanation": "652 \nSold by @itachibot T-cell acute lymphoblastic leukemia (T-ALL) is the most likely diagnosis since the chest X-ray \nshows superior mediastinal widening- indicating an involvement of the thymus gland. T-ALL accounts for about 15% of childhood ALL cases; it is more common in adolescents - this is \nthe time when the thymus reaches maximum size. 60% of patients with T-ALL present with a mediastinal mass. The mediastinal mass may be \nasymptomatic and detected only on chest x-ray or may cause cough and dyspnea, particularly on \nlying flat or with facial swelling and plethora due to vascular compression (superior vena cava \nsyndrome). B-ALL presents usually between 1-10 years of age perhaps because the number of normal bone \nmarrow pre-B-cells (the cell of origin) is greatest very early in life.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Paediatric Hemato-oncology"
    },
    {
      "q_no": 9,
      "question": "Question 9: A 2-month-old infant with seizures and failure to thrive has cutaneous nodules and \nhepatosplenomegaly. On investigations, CBC reveals hyperleukocytosis with a leukocyte count \nof 1,10,000cells/mm3. Peripheral smear and immunophenotyping studies reveal large, 642 \nSold by @itachibot irregular lymphoblasts, with a phenotype negative for the CD10 (common ALL antigen) \nmarker. On a cytogenetic study which of the following is most likely to be seen?",
      "options": {
        "a": "t(11, 14)",
        "b": "t (4,11)",
        "c": "t (12,21)",
        "d": "t (15,21)"
      },
      "correct_answer": "b",
      "explanation": "The above findings are diagnostic of Infantile acute lymphoblastic leukemia. Translocation (4;11) \ninvolving the MLL gene is most commonly associated with Infantile leukemia accounts for the \nvery high relapse rate. 2% of cases of leukemia during childhood occur before the age of 1 year and are referred to as \ninfantile leukemia. Patients often present with hyperleukocytosis and extensive tissue infiltration producing \norganomegaly. Subcutaneous nodules, known as leukemia cutis, caused by infiltration by \nleukemic cells are observed more often in infants than in older children. The leukemic cell morphology is usually that of large, irregular lymphoblasts, with a phenotype \nnegative for the CD10 (common ALL antigen) marker (pro-B), unlike most older children with \nB-ALL, who are CD10 +. Has a very poor prognosis. Note: Infants with AML present with CNS and skin involvement and most commonly have a subtype \nknown as acute myelomonocytic leukemia.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Paediatric Hemato-oncology"
    },
    {
      "q_no": 10,
      "question": "Question 10: A mother has noticed recently that her child refuses to be touched, seems to be in distress, \nand cries inconsolably. She brings her child to you who was investigated thoroughly and was \ndiagnosed to have acute lymphoblastic leukemia. Which of the following drugs can be used to \ntreat her?",
      "options": {
        "a": "Imatinib",
        "b": "L-asparaginase",
        "c": "Tretinoin",
        "d": "Cladribine"
      },
      "correct_answer": "b",
      "explanation": "L-asparaginase is used in the treatment of acute lymphoid leukaemia (ALL). ALL can present with \nhepatosplenomegaly, severe joint and bone pains that the kid refuses to be handled. It is observed that some lymphoid malignancies are unable to synthesize asparagine on their own \nand must derive it from the bloodstream. L-asparaginase catalyses circulating L-asparagine, \nthereby inhibiting protein synthesis in the cancer cells. Treatment of ALL • Induction: 4 weeks • L-asparaginase: single dose (side effects: pancreatitis, thrombosis) • Vincristine: weekly (side effects: neuropathy, SIADH) 653 \nSold by @itachibot • Prednisolone • Anthracycline • CNS prophylaxis- intrathecal methotrexate • Consolidation: • Methotrexate • Epipodophyllotoxin • Cyclophosphamide • Cytosine-Arabinoside • Maintenance: 24-36 months • 6-Mercaptopurine • Methotrexate Other options: • Imatinib is a tyrosine kinase inhibitor used to treat chronic myeloid leukemia and acute \nlymphoblastic leukemia with t(9;22) BCR-ABL fusion gene. • Tretinoin is used in acute promyelocytic leukaemia with t(15;17) PML-RARA fusion gene. • Cladribine is used in hairy cell leukaemia.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Paediatric Hemato-oncology"
    },
    {
      "q_no": 11,
      "question": "Question 11: You are posted in the hematology department as a pathologist. You are asked to report the \nbone marrow biopsy slide given below, which belongs to a 3-year-old child who is being \nevaluated for pancytopenia. To make a diagnosis of acute myeloid leukemia, what percentage \nof such cells should you visualize at the least? 643 \nSold by @itachibot",
      "options": {
        "a": "10",
        "b": "20",
        "c": "25",
        "d": "30"
      },
      "correct_answer": "b",
      "explanation": "Diagnosis of acute myeloid leukemia (AML) is confirmed by the presence of more than 20% \nmyeloblast cells (as shown in the image) in the bone marrow. Flow cytometry and special stains can be used to identify myeloperoxidase-containing cells, which \nconfirms the myelogenous origin of leukemia. Note: The diagnosis of acute lymphoid leukemia (ALL) requires the presence of more than 25% blasts in \nthe bone marrow.",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/mxpediatrics/Paediatric_Hemato-oncology_Q11_q.jpg",
      "explanation_image": null,
      "chapter_heading": "Paediatric Hemato-oncology"
    },
    {
      "q_no": 12,
      "question": "Question 12: A 3-year-old boy was brought to the pediatric OPD with complaints of persistent fever for the \npast 1 week. His CBC is given below:",
      "options": {
        "a": "t(8;21)",
        "b": "t(15;17)",
        "c": "Inv 16",
        "d": "Monosomy 7"
      },
      "correct_answer": "d",
      "explanation": "Monosomy 7 is associated with a poor prognosis in patients with acute myeloid leukemia (AML). The production of symptoms and signs of AML is a result of the replacement of bone marrow by \nmalignant cells and caused by secondary bone marrow failure-pallor, fatigue, exercise intolerance, \nbruising, oral mucosal bleeding, or epistaxis, as well as fever, which may be caused by infection or \nthe disease. In addition, patients with AML present with signs and symptoms that are uncommon in Acute \nlymphoblastic leukemia, including subcutaneous nodules or“blueberry muffin” lesions (especially 654 \nSold by @itachibot in infants), infiltration of the gingiva (especially in monocytic subtypes), signs and laboratory \nfindings of disseminated intravascular coagulation (especially indicative of acute promyelocytic \nleukemia), and discrete masses, known as chloromas or granulocytic sarcomas. Prognostic implications of chromosomal abnormalities in AML are given below: Favorable prognosis t(8;21); RUNX1-RUNX1T1Inv \n(16) or t(16;16); CBFNPM1m \nutationCEBPAmutation Poor prognosis inv(3)t(6;9)5q-del(7q)comple \nx karyotype (3 abnormalitie \ns)Monosomy7",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Paediatric Hemato-oncology"
    },
    {
      "q_no": 13,
      "question": "Question 13: A child with a violaceous, raised nodular skin lesion which on biopsy is found to be infiltrated \nby myeloblasts is likely suffering from which type of Acute myeloid leukemia (AML)?",
      "options": {
        "a": "AML M2",
        "b": "AML M3",
        "c": "AML M7",
        "d": "AML M1"
      },
      "correct_answer": "a",
      "explanation": "Nodular, violaceous skin lesion infiltrated with myeloblasts is descriptive of Chloroma otherwise \nknown as extramedullary myeloblastoma or granulocytic(myeloid) sarcoma. Myeloid sarcomas are \nseen in AML subtypes M2, M4, M5a, and M5b. “Chloroma” was coined due to the peculiar green color of the tumor caused by myeloperoxidase \npresent in tumor cells. These masses can occur in the absence of apparent bone marrow involvement and typically are \nassociated with t(8;21) translocation. Chloromas also may be seen in the orbit and epidural space.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Paediatric Hemato-oncology"
    },
    {
      "q_no": 14,
      "question": "Question 14: Erythemic myelosis is  \n.",
      "options": {
        "a": "AML M2",
        "b": "AML M5",
        "c": "AML M7",
        "d": "AML M6"
      },
      "correct_answer": "d",
      "explanation": "Erythemic myelosis is AML M6. Constitute about 1% of AML cases Two subtypes of AML M6: • Erythroid or myeloid leukemia: M6a (more common) • Pure erythroid leukemia: M6b, also called erythemic myelosis (Di Guglielmo disease).",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Paediatric Hemato-oncology"
    },
    {
      "q_no": 15,
      "question": "Question 15: A neonate with trisomy 21 has anemia, petechiae, hepatosplenomegaly, and no \nlife-threatening complications on examination.CBC reveals high leucocyte count and \nperipheral smear shows numerous myeloblasts. The genetic makeup of blast cells when \nstudied reveals GATA-1 mutations. At 3 months of age, his CBC counts come back to normal \nand there are no blast cells in his peripheral smear. As his treating physician, what would you \nrecommend?",
      "options": {
        "a": "Chemotherapy",
        "b": "Radiotherapy",
        "c": "Bone marrow transplant",
        "d": "A close follow-up"
      },
      "correct_answer": "d",
      "explanation": "This infant has a transient myeloproliferative disease, which usually resolves spontaneously in the \nfirst 3 months of life, and they require close-follow up because 20–30% will develop typical \nleukemia (acute megakaryocytic leukemia) by 3 years of life. 655 \nSold by @itachibot Approximately 10% of neonates with Down syndrome develop transient leukemia or \nmyeloproliferative disorder characterized by high leukocyte counts, blast cells in the peripheral \nblood, and associated anemia, thrombocytopenia, and hepatosplenomegaly. These features \nusually resolve within the first 3 months of life. Although these neonates can require temporary \ntransfusion support, they do not require chemotherapy unless there is evidence of life-threatening \ncomplications. As only 20-30% of such children develop acute megakaryocytic leukemia a bone marrow \ntransplant would be a drastic step in our case.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Paediatric Hemato-oncology"
    },
    {
      "q_no": 16,
      "question": "Question 16: An 18-month-old child presents to the pediatric OPD with complaints of fever and rashes for \nthe past 1 week after extensive workup gets diagnosed as Juvenile chronic myeloid leukemia. \nWhich of the following findings is not consistent with this baby’s diagnosis?",
      "options": {
        "a": "The genetic study may reveal NF-1 mutation",
        "b": "The presence of Philadelphia chromosome on FISH",
        "c": "The bone marrow shows a myelodysplastic pattern with &lt;20% blasts.",
        "d": "The peripheral smear reveals nucleated RBCs"
      },
      "correct_answer": "b",
      "explanation": "Patients with juvenile myelomonocytic leukemia do not have the Philadelphia chromosome. Formerly termed juvenile chronic myeloid leukemia (CML), it is a clonal proliferation of \nhematopoietic stem cells that typically affects children younger than 2 years of age. Patients with \nJMML present with rashes, lymphadenopathy, splenomegaly, and hemorrhagic manifestations. Patients with this disease do not have the Philadelphia chromosome (the Philadelphia \nchromosome is characteristic of CML). The peripheral blood smear shows an elevated leukocyte \ncount with increased monocytes, thrombocytopenia, and anemia with the presence of \nerythroblasts. Bone marrow shows a myelodysplastic pattern, with blasts accounting for &lt;20% \nof cells. Patients with neurofibromatosis type 1 and Noonan syndrome have a predilection for this \ntype of leukemia. JMML in the setting of Noonan syndrome is unique, with most patients having a spontaneous \nresolution.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Paediatric Hemato-oncology"
    },
    {
      "q_no": 17,
      "question": "Question 17: The most common non-Hodgkin's lymphoma in children is  \n. 645 \nSold by @itachibot",
      "options": {
        "a": "B-cell acute lymphoblastic leukemia (B-ALL)",
        "b": "Mantle cell lymphoma",
        "c": "Diffuse large B-cell lymphoma (DLBCL)",
        "d": "Burkitt lymphoma"
      },
      "correct_answer": "d",
      "explanation": "Burkitt lymphoma is the most common non-Hodgkin's lymphoma in children under the age of 15 \nyears. Diffuse large B-cell lymphoma (DLBCL) is the most common form of non-Hodgkin lymphoma \n(NHL) in adults and adolescents (15-19) years, worldwide. B-cell acute lymphoblastic leukemia (B-ALL) is the most common childhood malignancy and the \nmost common leukemia in children. (It is not a non-Hodgkin's lymphoma).",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Paediatric Hemato-oncology"
    },
    {
      "q_no": 18,
      "question": "Question 18: Which of the following statements best describe the behavior of Non-Hodgkin lymphoma in a \n10-year-old child?",
      "options": {
        "a": "Is dominantly nodal",
        "b": "Is of high grade and aggressive",
        "c": "Has variable growth fraction",
        "d": "Has poor outcome"
      },
      "correct_answer": "b",
      "explanation": "In contrast to adult non-Hodgkin's lymphoma (NHL), which is typically indolent, pediatric NHL is \nusually high-grade and aggressive. NHL in the pediatric age group has distinct clinical and behavior properties when compared to \nadults. These include the following: 656 \nSold by @itachibot NHL in adults \nNHL in children Low/intermediate grade \nHigh grade Dominantly nodal \nExtra-nodal High growth fractio \nn Variable growth fractio \nn Good outcome Poor long-term outcom \ne",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Paediatric Hemato-oncology"
    },
    {
      "q_no": 19,
      "question": "Question 19: A 6-year-old boy is brought with complaints of abdominal distension, fatigue, and night \nsweats for the past 4 months. He also has a 2-month history of postprandial fullness and \nrecurrent non-bilious vomiting. On examination, he is pale, has hepatosplenomegaly and \nshifting dullness. A CT scan shows mesenteric and retroperitoneal lymph node enlargement. \nA biopsy specimen of the mesenteric lymph node reveals tumor cells with high mitotic index \nand starry sky pattern. The cytogenetic study revealed t(8;14).To stage the disease, which of \nthe following systems would you use?",
      "options": {
        "a": "Ann-Arbor staging",
        "b": "Binet staging",
        "c": "St Jude staging",
        "d": "RAI staging"
      },
      "correct_answer": "c",
      "explanation": "Retroperitoneal and mesenteric lymphadenopathy with hepatosplenomegaly, anemia, and short \nduration of disease, point towards a diagnosis of lymphoid neoplasms.The classic translocation of \nt(8;14) and starry sky appearance with a high mitotic index on HPE point toward a diagnosis of \nBurkitt lymphoma. Burkitt’s lymphoma is the most common type of Non-Hodgkin lymphoma \nworldwide. St Jude system of staging is used for staging childhood non-Hodgkin lymphoma. The current revised staging system used for NHL is the International Pediatric Non-Hodgkin \nLymphoma Staging System (IPNHLSS) which reflects our increasing ability to diagnose lower \nlevels of organ involvement with disease. For instance, the older staging system (St. Jude/Murphy \nclassification) did not account for molecular or flow cytometry involvement of bone marrow, \nwhich is now reflected in the new system. Disease \nSystem of staging Hodgkin lymphoma \nAnn–Arbor staging Non-Hodgkin Lymphom \na St Jude(Murphy) stagin \ng Chronic lymphoid leuke \nmia Rai stagingBinet staging",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Paediatric Hemato-oncology"
    },
    {
      "q_no": 20,
      "question": "Question 20: A lymph node biopsy of a 9-year-old child with cervical lymphadenopathy showed the \nfollowing picture. The diagnosis is \n. 646 \nSold by @itachibot",
      "options": {
        "a": "Burkitt Lymphoma",
        "b": "Hodgkin's disease",
        "c": "Acute lymphoblastic leukemia",
        "d": "Chloroma"
      },
      "correct_answer": "b",
      "explanation": "In the picture given above, Reed–Sternberg (RS) cells are seen, which is a pathognomonic feature \nof Hodgkin's lymphoma (HL). Reed–Sternberg cells are large and either multinucleated or have a bilobed nucleus (thus \nresembling an \"owl's eye\" appearance) with prominent eosinophilic inclusion-like nucleoli. The RS \ncell is clonal in origin and arises from the germinal center B cells but typically has lost most B-cell \ngene expression and function. Hodgkin lymphoma encompasses a group of lymphoid neoplasms that typically arise in a signal \nnode or chain of nodes and spread first to anatomically contiguous sites. WHO classification of Hodgkin lymphoma includes 5 subtypes namely; 657 \nSold by @itachibot • Nodular sclerosis • Mixed cellularity • Lymphocyte-rich • Lymphocyte depletion • Nodular lymphocyte predominance",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/mxpediatrics/Paediatric_Hemato-oncology_Q20_q.jpg",
      "explanation_image": null,
      "chapter_heading": "Paediatric Hemato-oncology"
    },
    {
      "q_no": 21,
      "question": "Question 21: A 12- year-old female comes to you with a flu-like illness and left supraclavicular swelling of \nuncertain nature. Her chest X-ray shows left mediastinal enlargement. CT scan of the chest \nand abdomen reveals the presence of enlarged lymph nodes in the neck, mediastinum, and \nliver, and an FDG-PET/CT scan shows multiple scattered consolidation lesions involving also \nthe bones. The diagnosis of classical Hodgkin’s lymphoma, nodular sclerosis subtype, is made \non cervical lymph node biopsy. According to Ann-Arbor's staging system, how will you stage \nher disease?",
      "options": {
        "a": "2",
        "b": "1",
        "c": "4",
        "d": "3"
      },
      "correct_answer": "c",
      "explanation": "The clinical vignette describes Hodgkin’s lymphoma with the involvement of liver and bone \nmarrow, which is classified as Stage 4 according to Ann-Arbor staging. Ann Arbor Staging of Hodgkin’s Lymphoma Stage I \nInvolvement of asinglelymph \nnode (I) or Lymphoid structu \nre(eg: spleen, thymus, Waldy \ner's ring) Involvement of 2 or more ly \nmph node regions on thesam \ne side of the diaphragm Stage I \nI Stage I \nII Involvement of lymph node r \negions or lymphoid structure \ns on both sides of thediaphra \ngm (III) 658 \nSold by @itachibot Stage I Involvement of asinglelymph node (I) or Lymphoid structu \nre(eg: spleen, thymus, Waldy \ner's ring) Stage I \nV Involvement of extranodal sit \ne beyond that designated as ' \nE'More than one extranodal \ndeposit at any locationAny in \nvolvement of liver or bone m \narrow A \nNo symptoms B \nThe presence of fever >38°C ( \n100.4°F) for 3 consecutive da \nysRecurrent drenching night \nsweatsUnexplained loss of >1 \n0% of body weight in the 6 m \nonths E \nLocalized, solitary involveme \nnt of extra lymphatic tissue, e \nxcluding liver and bone marr \now",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Paediatric Hemato-oncology"
    },
    {
      "q_no": 22,
      "question": "Question 22: The following parameter in ALL indicate a poor prognosis  \n.",
      "options": {
        "a": "Age &gt;10 years",
        "b": "Leukocyte count &lt;50,000/mm3",
        "c": "Hyperdiploidy",
        "d": "Trisomy of chromosomes 4, 10, and 17"
      },
      "correct_answer": "a",
      "explanation": "Age &gt;10 years indicates a poor prognosis in ALL. Leukocyte count &lt;50,000/mm3, hyperdiploidy, and trisomy of chromosomes 4,10,17 indicate a \ngood prognosis.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Paediatric Hemato-oncology"
    },
    {
      "q_no": 23,
      "question": "Question 23: Sanctuary sites of acute lymphoblastic leukemia are \n.",
      "options": {
        "a": "Central nervous system",
        "b": "Testis",
        "c": "Both A and B",
        "d": "None of the above"
      },
      "correct_answer": "c",
      "explanation": "Both CNS and testis are considered as sanctuary sites of acute lymphoblastic leukemia (ALL). • A sanctuary site is an area of the body that is poorly penetrated by pharmacological agents and, \ntherefore, serves as a place in which tumor cells or infectious organisms can escape the effects of \ndrug therapy. • Early institution of CNS prophylaxis (intrathecal methotrexate) is essential to eradicate these \nescaped leukemic cells. • Testicular involvement is rarely evident at diagnosis, testicular involvement can present as \npainless testicular enlargement.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Paediatric Hemato-oncology"
    },
    {
      "q_no": 24,
      "question": "Question 24: A 4-year-old boy presents with pancytopenia and hepatosplenomegaly. Bony tenderness is \nalso present. He is most likely suffering from the following type of ALL \n.",
      "options": {
        "a": "Medulloblastoma",
        "b": "Pilocytic astrocytoma",
        "c": "Ependymoma",
        "d": "Choroid plexus carcinoma"
      },
      "correct_answer": "a",
      "explanation": "659 \nSold by @itachibot B-cell lymphoblastic leukemia (L1) • This is the most common immunophenotype of acute lymphocytic leukemia (ALL) in a child \nbetween the ages of 1-10 years. • They present with features of bone marrow failure and organ infiltration such as pancytopenia \nand hepatosplenomegaly, respectively, so B-cell ALL is the most likely diagnosis. • Bony tenderness may be present due to sub-periosteal infiltration of lymphoblastic cells. • T-cell ALL (L2) typically presents in adolescent boys with a large anterior mediastinal mass \n(thymus or mediastinal lymph nodes), causing respiratory distress or superior vena cava \nobstruction. 660 \nSold by @itachibot Solid Neoplasms of Childhood",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/mxpediatrics/Paediatric_Hemato-oncology_Q24_q.jpg",
      "explanation_image": null,
      "chapter_heading": "Paediatric Hemato-oncology"
    }
  ]
}
